AdaptHealth Corp

For the period ended Dec 31, 2024. Filed Feb 25, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 25, 2025

AHCO$7.72+5.0%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations—For the years ended and

(in thousands, except per share data)

	Year Ended December 31,
	2024	2023	2022
Net revenue	$3,260,975	$3,200,177	$2,970,595
Costs and expenses:
Cost of net revenue	2,579,882	2,576,110	2,390,480
General and administrative expenses	359,238	334,594	324,814
Depreciation and amortization, excluding patient equipment depreciation	45,045	57,087	64,890
Goodwill impairment (note 7)	13,078	830,787	—
Total costs and expenses	2,997,243	3,798,578	2,780,184
Operating income (loss)	263,732	(598,401)	190,411
Interest expense, net	126,668	130,299	109,414
Loss on extinguishment of debt	2,273	—	—
Change in fair value of warrant liability (note 13)	(4,021)	(34,482)	(17,158)
Other loss, net	2,793	29,566	253
Income (loss) before income taxes	136,019	(723,784)	97,902
Income tax expense (benefit)	41,239	(49,004)	24,769
Net income (loss)	94,780	(674,780)	73,133
Income attributable to noncontrolling interest	4,358	4,115	3,817
Net income (loss) attributable to AdaptHealth Corp.	$90,422	$(678,895)	$69,316
Weighted average common shares outstanding - basic	133,756	134,156	134,175
Weighted average common shares outstanding - diluted	135,531	134,418	138,988
Basic net income (loss) per share (note 14)	$0.62	$(5.06)	$0.47
Diluted net income (loss) per share (note 14)	$0.61	$(5.31)	$0.33

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.